tiRNA-Pro-AGG-001 serves as a host-directed prognostic biomarker and therapeutical target for pediatric sepsis

Lihong Wu, Chenfang Zeng, Changxue Xiao, Yueqiang Fu, Ke Bai, Jing Li, Feng Xu, Hongxing Dang

Open source

DOI
10.1016/j.intimp.2026.117518
Published
2026-12
Container
International Immunopharmacology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.intimp.2026.117518,
  title = {tiRNA-Pro-AGG-001 serves as a host-directed prognostic biomarker and therapeutical target for pediatric sepsis},
  author = {Lihong Wu and Chenfang Zeng and Changxue Xiao and Yueqiang Fu and Ke Bai and Jing Li and Feng Xu and Hongxing Dang},
  year = {2026},
  journal = {International Immunopharmacology},
  doi = {10.1016/j.intimp.2026.117518},
  url = {https://doi.org/10.1016/j.intimp.2026.117518}
}

RIS

TY  - JOUR
TI  - tiRNA-Pro-AGG-001 serves as a host-directed prognostic biomarker and therapeutical target for pediatric sepsis
AU  - Lihong Wu
AU  - Chenfang Zeng
AU  - Changxue Xiao
AU  - Yueqiang Fu
AU  - Ke Bai
AU  - Jing Li
AU  - Feng Xu
AU  - Hongxing Dang
PY  - 2026
JO  - International Immunopharmacology
DO  - 10.1016/j.intimp.2026.117518
UR  - https://doi.org/10.1016/j.intimp.2026.117518
ER  - 

APA

Wu, L., Zeng, C., Xiao, C., Fu, Y., Bai, K., Li, J., Xu, F., & Dang, H. (2026). tiRNA-Pro-AGG-001 serves as a host-directed prognostic biomarker and therapeutical target for pediatric sepsis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117518

Source records